Elicio Therapeutics, Inc. Shares Outstanding (Cover Page)
Elicio Therapeutics, Inc. (ELTX) had Shares Outstanding (Cover Page) of 26.28 million shares as of 2026-08-11, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-11: Entity Common Stock, Shares Outstanding 26.28M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 19.09M shares.
- 2026-04-09: Entity Common Stock, Shares Outstanding 18.70M shares.
- 2026-03-10: Entity Common Stock, Shares Outstanding 18.40M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-11 | 26.28M shares 10-Q · filed 2026-08-13 |
| 2026-05-08 | 19.09M shares 10-Q · filed 2026-05-11 |
| 2026-04-09 | 18.70M shares 10-K/A · filed 2026-04-29 |
| 2026-03-10 | 18.40M shares 10-K · filed 2026-03-12 |
| 2025-11-10 | 17.49M shares 10-Q · filed 2025-11-13 |
| 2025-08-05 | 16.34M shares 10-Q · filed 2025-08-07 |
| 2025-05-09 | 16.00M shares 10-Q · filed 2025-05-13 |
| 2025-03-25 | 15.95M shares 10-K · filed 2025-03-31 |
| 2024-11-08 | 10.79M shares 10-Q · filed 2024-11-13 |
| 2024-08-09 | 10.77M shares 10-Q · filed 2024-08-13 |
| 2024-05-10 | 10.27M shares 10-Q · filed 2024-05-15 |
| 2024-04-10 | 10.23M shares 10-K/A · filed 2024-04-29 |
| 2024-03-26 | 10.24M shares 10-K · filed 2024-03-29 |
| 2023-11-07 | 8.41M shares 10-Q · filed 2023-11-13 |
| 2023-08-10 | 8.39M shares 10-Q · filed 2023-08-14 |
| 2023-05-05 | 30.11M shares 10-Q · filed 2023-05-10 |
| 2023-03-15 | 30.11M shares 10-K/A · filed 2023-04-28 |
| 2022-11-08 | 30.11M shares 10-Q · filed 2022-11-14 |
| 2022-08-08 | 30.11M shares 10-Q · filed 2022-08-15 |
| 2022-05-13 | 29.96M shares 10-Q · filed 2022-05-16 |
| 2022-03-25 | 29.96M shares 10-K · filed 2022-03-30 |
| 2021-11-05 | 29.96M shares 10-Q · filed 2021-11-12 |
| 2021-08-10 | 29.80M shares 10-Q · filed 2021-08-12 |
| 2021-05-14 | 29.66M shares 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |